role for T cell-derived interleukin 22 in psoriatic skin inflammation
Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-...
Saved in:
Published in | Clinical and experimental immunology Vol. 150; no. 3; pp. 407 - 415 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.12.2007
Blackwell Publishing Ltd Blackwell Wiley Blackwell Science Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis. |
---|---|
AbstractList | Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis. Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis. Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory-like phenotype. In the present study, we assessed the presence of IL-22 and the IL-22 receptor 1 (IL-22R1) in skin lesions, skin-derived T cells, as well as IL-22 levels in sera from patients with psoriasis. IL-22R1 and IL-10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL-22 mRNA expression was up-regulated in psoriatic skin lesions compared to normal skin, whereas IL-22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL-22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL-22 in comparison to peripheral T cells isolated from the same patients. IL-10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin-infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL-22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis. Summary Interleukin (IL)‐22 is a T cell‐derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis, and to induce in vitro an inflammatory‐like phenotype. In the present study, we assessed the presence of IL‐22 and the IL‐22 receptor 1 (IL‐22R1) in skin lesions, skin‐derived T cells, as well as IL‐22 levels in sera from patients with psoriasis. IL‐22R1 and IL‐10R2 transcripts are expressed at a similar level in psoriatic and healthy skin. In contrast, IL‐22 mRNA expression was up‐regulated in psoriatic skin lesions compared to normal skin, whereas IL‐22 mRNA levels in peripheral blood mononuclear cells from psoriatic patients and normal subjects were similar. Circulating IL‐22 levels were significantly higher in psoriatic patients than in normal subjects. T cells isolated from psoriatic skin produced higher levels of IL‐22 in comparison to peripheral T cells isolated from the same patients. IL‐10 was expressed at similar levels in skin biopsies and peripheral blood mononuclear cells of psoriatic patients and normal subjects. Finally, we show here that supernatants of lesional psoriatic skin‐infiltrating T cells induce an inflammatory response by normal human epidermal keratinocytes, resembling that observed in psoriatic lesions. Taken together, the results reported in this study indicate that IL‐22 is a cytokine produced by skin‐infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis. |
Author | Delwail, A Garcia, M Dagregorio, G Boniface, K Nau, F Yssel, H Lecron, J.-C Guillet, G Guignouard, E Bernard, F.-X Morel, F Pedretti, N |
Author_xml | – sequence: 1 fullname: Boniface, K – sequence: 2 fullname: Guignouard, E – sequence: 3 fullname: Pedretti, N – sequence: 4 fullname: Garcia, M – sequence: 5 fullname: Delwail, A – sequence: 6 fullname: Bernard, F.-X – sequence: 7 fullname: Nau, F – sequence: 8 fullname: Guillet, G – sequence: 9 fullname: Dagregorio, G – sequence: 10 fullname: Yssel, H – sequence: 11 fullname: Lecron, J.-C – sequence: 12 fullname: Morel, F |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19869088$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17900301$$D View this record in MEDLINE/PubMed https://univ-poitiers.hal.science/hal-01705160$$DView record in HAL |
BookMark | eNqNUk1v1DAQtVAR3Rb-AuQCEoeEGSd24gOVqtX2Q1qJA-3Zchyn9ZKNFzu7tP8ep7tsoZfFB3-M33vjGb8TctS73hCSIGQYx5dFhjlnKaWFyChAmUHOELOHV2SyvzgiEwAQqUAojslJCIt45JzTN-QYSwGQA07IzLvOJK3zyU2iTdeljfF2Y5rE9oPxnVn_sH1CaTwmq-C8VYPVSRiDtm87tVzGgOvfktet6oJ5t1tPye3F7GZ6lc6_XV5Pz-ep5pRiygQabZDnDbJa1Ni0qqhL5Ew1FXLVMKVAVwU2hhemRsFK0WpamJbFWRvIT8nZVne1rpem0aYfvOrkytul8o_SKSv_ventvbxzGxmzi7zMo8DnrcD9C9rV-VyOMcASGHLYYMR-2iXz7ufahEEubRh7pHrj1kHyikFOGT8ILMpCIKfiIJACA1ryIgLf_13n_qV__i0CPu4AKmjVtV712oZnnKi4gKp6bpj2LgRvWqnt8PRlsT22kwhyNJRcyNE3cvSNHA0lnwwlH6JA9UJgn-Mw9euW-st25vG_eXI6ux53kf9hy2-Vk-rOx_puv9NYPEBFGVZF_hsPL-ng |
CODEN | CEXIAL |
CitedBy_id | crossref_primary_10_1016_j_sder_2010_03_001 crossref_primary_10_1016_j_jff_2021_104352 crossref_primary_10_1371_journal_pone_0140750 crossref_primary_10_1371_journal_pcbi_1001024 crossref_primary_10_3390_ijms21093303 crossref_primary_10_4049_jimmunol_1000847 crossref_primary_10_2177_jsci_34_13 crossref_primary_10_1016_j_cytogfr_2010_10_007 crossref_primary_10_1111_jgh_13537 crossref_primary_10_1155_2014_182549 crossref_primary_10_1189_JLB_0109046 crossref_primary_10_3390_ijms20071670 crossref_primary_10_1038_jid_2009_59 crossref_primary_10_1074_jbc_M114_573071 crossref_primary_10_1186_ar4317 crossref_primary_10_1016_j_humimm_2024_110814 crossref_primary_10_1016_j_intimp_2015_11_005 crossref_primary_10_1002_cti2_1017 crossref_primary_10_1016_j_febslet_2009_03_006 crossref_primary_10_4049_jimmunol_0902464 crossref_primary_10_1007_s10875_008_9233_0 crossref_primary_10_1172_jci_insight_86434 crossref_primary_10_1155_2013_856056 crossref_primary_10_1002_hep_26528 crossref_primary_10_1016_j_jprot_2016_03_040 crossref_primary_10_1016_j_cyto_2013_08_005 crossref_primary_10_1038_s41598_019_43899_9 crossref_primary_10_1016_j_cyto_2024_156617 crossref_primary_10_1016_j_trsl_2019_10_004 crossref_primary_10_1517_14728222_2013_838220 crossref_primary_10_1016_j_immuni_2011_08_001 crossref_primary_10_4049_jimmunol_1001001 crossref_primary_10_3389_fimmu_2021_584414 crossref_primary_10_5021_ad_2016_28_5_579 crossref_primary_10_1038_ni_3742 crossref_primary_10_1111_jocd_13779 crossref_primary_10_1056_NEJMe1201071 crossref_primary_10_4049_jimmunol_1000824 crossref_primary_10_1002_eji_201041131 crossref_primary_10_1101_cshperspect_a028548 crossref_primary_10_1016_j_bmcl_2015_03_025 crossref_primary_10_1196_annals_1443_021 crossref_primary_10_1177_1721727X1301100303 crossref_primary_10_1586_1744666X_2014_884461 crossref_primary_10_1016_j_biopha_2017_05_005 crossref_primary_10_1016_j_jdin_2022_08_008 crossref_primary_10_3390_life13051076 crossref_primary_10_1016_j_jaci_2018_09_032 crossref_primary_10_1016_j_clim_2009_11_008 crossref_primary_10_4049_jimmunol_1103173 crossref_primary_10_3390_v16030425 crossref_primary_10_1371_journal_pone_0062154 crossref_primary_10_1016_j_jdermsci_2013_04_028 crossref_primary_10_1016_j_bcp_2013_11_012 crossref_primary_10_1089_jir_2013_0099 crossref_primary_10_1002_art_38376 crossref_primary_10_1016_j_jep_2022_115275 crossref_primary_10_1177_1535370217710637 crossref_primary_10_1182_blood_2008_06_162420 crossref_primary_10_1111_j_1600_0536_2008_01454_x crossref_primary_10_1007_s00018_020_03726_1 crossref_primary_10_1007_s10571_021_01153_9 crossref_primary_10_3390_cells10061392 crossref_primary_10_4049_jimmunol_1401244 crossref_primary_10_1111_bph_12196 crossref_primary_10_1016_j_jaci_2012_05_003 crossref_primary_10_1371_journal_pone_0018741 crossref_primary_10_1016_j_cellimm_2008_10_002 crossref_primary_10_1111_bjd_13236 crossref_primary_10_3389_fmolb_2023_1196323 crossref_primary_10_4049_jimmunol_181_12_8504 crossref_primary_10_1038_srep44172 crossref_primary_10_1038_s41598_018_23510_3 crossref_primary_10_1371_journal_pone_0182646 crossref_primary_10_1111_exd_14551 crossref_primary_10_1016_j_jaci_2009_03_041 crossref_primary_10_1007_s12026_022_09325_5 crossref_primary_10_1016_j_cytogfr_2010_08_001 crossref_primary_10_1371_journal_ppat_1001144 crossref_primary_10_1073_pnas_0911472106 crossref_primary_10_1111_ijd_12883 crossref_primary_10_1038_s41598_018_38156_4 crossref_primary_10_1016_j_jdermsci_2013_03_011 crossref_primary_10_1172_JCI40202 crossref_primary_10_1038_icb_2011_79 crossref_primary_10_3389_fimmu_2023_1081256 crossref_primary_10_1007_s00018_010_0380_0 crossref_primary_10_1016_j_immuni_2008_03_002 crossref_primary_10_1038_jid_2014_81 crossref_primary_10_1016_j_imbio_2013_05_005 crossref_primary_10_4049_jimmunol_0903907 crossref_primary_10_1038_s41598_025_90961_w crossref_primary_10_1002_eji_201040878 crossref_primary_10_1182_blood_2010_01_263509 crossref_primary_10_1002_eji_201546070 crossref_primary_10_1016_j_cyto_2023_156293 crossref_primary_10_5005_jp_journals_10047_0015 crossref_primary_10_1038_jid_2011_486 crossref_primary_10_1517_14728222_2013_736497 crossref_primary_10_1016_j_cyto_2014_09_007 crossref_primary_10_3389_fmicb_2021_729053 crossref_primary_10_1016_j_ajpath_2012_12_007 crossref_primary_10_1016_j_heliyon_2022_e08729 crossref_primary_10_1074_jbc_M111_286492 crossref_primary_10_1517_14728210902771334 crossref_primary_10_1111_j_1346_8138_2011_01458_x crossref_primary_10_1097_01_EWX_0000511083_73976_6f crossref_primary_10_1016_j_jaci_2013_01_029 crossref_primary_10_1111_exd_13270 crossref_primary_10_1155_2016_4395276 crossref_primary_10_1038_s41598_017_01468_y crossref_primary_10_1016_j_cyto_2013_03_013 crossref_primary_10_1016_j_jep_2020_112760 crossref_primary_10_1016_j_jaci_2010_07_041 crossref_primary_10_4110_in_2018_18_e42 crossref_primary_10_1002_eji_201445144 crossref_primary_10_1042_BSR20203130 crossref_primary_10_1172_JCI37378 crossref_primary_10_3390_app112411599 crossref_primary_10_1016_j_jid_2018_07_032 crossref_primary_10_3389_fimmu_2021_618110 crossref_primary_10_1111_j_1600_0625_2009_00840_x crossref_primary_10_3389_fimmu_2017_00978 crossref_primary_10_4049_jimmunol_1102224 crossref_primary_10_1016_j_jaci_2015_01_033 crossref_primary_10_1002_eji_200939473 crossref_primary_10_1002_eji_201141958 crossref_primary_10_3892_mmr_2016_5108 crossref_primary_10_1007_s13277_016_5030_1 crossref_primary_10_2147_PTT_S335913 crossref_primary_10_3389_fimmu_2019_00589 crossref_primary_10_1021_acs_jafc_8b02524 crossref_primary_10_1007_s13671_012_0017_7 crossref_primary_10_1371_journal_pone_0119872 crossref_primary_10_1007_s12325_022_02241_y crossref_primary_10_1111_j_1346_8138_2011_01462_x crossref_primary_10_1080_15321810903405100 crossref_primary_10_1111_1346_8138_17065 crossref_primary_10_1007_s11010_012_1389_5 crossref_primary_10_1111_j_1600_065X_2008_00714_x crossref_primary_10_1016_j_jaut_2021_102634 crossref_primary_10_1155_2015_819149 crossref_primary_10_1111_imr_12322 crossref_primary_10_1155_2012_718725 crossref_primary_10_1111_j_1365_2133_2008_08769_x crossref_primary_10_1111_1346_8138_12961 crossref_primary_10_1096_fj_10_172288 crossref_primary_10_1194_jlr_M044305 crossref_primary_10_1097_ACI_0b013e32834a977a crossref_primary_10_1371_journal_pone_0212043 crossref_primary_10_1016_j_jhep_2010_03_004 crossref_primary_10_1016_j_atherosclerosis_2015_08_006 crossref_primary_10_1186_ar3090 crossref_primary_10_1038_ni_1956 crossref_primary_10_1016_j_intimp_2015_05_030 crossref_primary_10_2217_imt_2018_0028 crossref_primary_10_1016_j_cytogfr_2014_04_005 crossref_primary_10_1016_j_jaci_2010_11_050 crossref_primary_10_1016_j_str_2008_06_005 crossref_primary_10_1007_s11926_014_0414_y crossref_primary_10_1080_17476348_2016_1174580 crossref_primary_10_1111_sji_12764 crossref_primary_10_1016_j_cellimm_2009_04_005 crossref_primary_10_1002_eji_200939687 crossref_primary_10_3390_ijms19010179 crossref_primary_10_1586_eci_09_64 crossref_primary_10_1111_bjd_14164 crossref_primary_10_1016_j_intimp_2013_02_018 crossref_primary_10_3389_fphar_2017_00125 crossref_primary_10_1111_imr_12027 crossref_primary_10_4049_jimmunol_1801426 crossref_primary_10_4291_wjgp_v7_i1_108 crossref_primary_10_3389_fimmu_2016_00148 crossref_primary_10_1111_cod_12043 crossref_primary_10_1038_icb_2009_68 crossref_primary_10_1038_ni_2025 crossref_primary_10_1111_ijd_12808 crossref_primary_10_1186_s40364_022_00382_4 crossref_primary_10_1096_fj_202101800R crossref_primary_10_1007_s00281_009_0188_x crossref_primary_10_1016_j_jdermsci_2013_04_002 crossref_primary_10_1016_j_intimp_2020_106439 crossref_primary_10_4049_jimmunol_1400205 crossref_primary_10_1038_labinvest_2011_76 crossref_primary_10_1002_eji_201546216 crossref_primary_10_1042_CS20110496 crossref_primary_10_1016_j_ajpath_2012_11_030 crossref_primary_10_1111_imm_12871 crossref_primary_10_1016_j_pan_2014_08_005 crossref_primary_10_1146_annurev_immunol_032414_112123 crossref_primary_10_1038_ni_1767 crossref_primary_10_1586_1744666X_2015_1023295 crossref_primary_10_1038_cmi_2012_15 crossref_primary_10_1016_j_jaut_2022_102916 crossref_primary_10_1051_medsci_201026112 crossref_primary_10_3892_ijo_2012_1594 crossref_primary_10_1111_dth_14209 crossref_primary_10_1155_2019_6276254 crossref_primary_10_1016_j_jconrel_2018_05_040 crossref_primary_10_1111_bjh_12616 crossref_primary_10_1038_ni_1770 crossref_primary_10_3892_mmr_2017_6942 crossref_primary_10_1007_s12016_012_8306_2 crossref_primary_10_1111_1346_8138_12248 crossref_primary_10_1007_s00005_018_0527_5 crossref_primary_10_4049_jimmunol_1700021 crossref_primary_10_3389_fimmu_2020_606489 crossref_primary_10_1016_j_jid_2016_12_023 crossref_primary_10_1002_eji_202149485 crossref_primary_10_1111_j_1365_2567_2009_03240_x crossref_primary_10_1111_dth_12160 crossref_primary_10_1038_s41598_017_13858_3 crossref_primary_10_1146_annurev_immunol_031210_101312 crossref_primary_10_4049_jimmunol_1300575 |
Cites_doi | 10.1189/jlb.0704409 10.1002/eji.200535503 10.4049/jimmunol.168.11.5397 10.1093/hmg/10.17.1793 10.4049/jimmunol.166.12.7096 10.1074/jbc.M007837200 10.1016/j.intimp.2004.01.008 10.1073/pnas.171303198 10.1038/nri1689 10.4049/jimmunol.178.7.4615 10.1186/gb-2002-3-7-research0034 10.1172/JCI1476 10.1074/jbc.M204204200 10.1074/jbc.M005304200 10.1089/107999001317205178 10.1016/j.it.2006.12.005 10.1073/pnas.170291697 10.1046/j.1523-1747.2001.01248.x 10.1177/002215540305100513 10.4049/jimmunol.164.4.1814 10.1016/j.it.2004.03.006 10.1111/1523-1747.ep12371752 10.1016/j.immuni.2004.07.007 10.1016/1043-4666(90)90045-U 10.1038/nature05505 10.4049/jimmunol.174.6.3695 10.1111/1523-1747.ep12371679 10.1084/jem.20061308 10.1007/s00403-004-0460-9 10.1038/ni1497 10.1016/S0022-1759(03)00010-3 10.1111/j.1365-2133.2005.06800.x 10.1001/archderm.135.2.187 10.1016/j.coi.2006.03.017 10.4049/jimmunol.166.12.7090 10.4049/jimmunol.173.3.2151 10.1038/nm0307-242 |
ContentType | Journal Article |
Copyright | 2008 INIST-CNRS Distributed under a Creative Commons Attribution 4.0 International License 2007 British Society for Immunology 2007 |
Copyright_xml | – notice: 2008 INIST-CNRS – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: 2007 British Society for Immunology 2007 |
DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7S9 L.6 7X8 1XC 5PM |
DOI | 10.1111/j.1365-2249.2007.03511.x |
DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1365-2249 |
EndPage | 415 |
ExternalDocumentID | PMC2219373 oai_HAL_hal_01705160v1 17900301 19869088 10_1111_j_1365_2249_2007_03511_x CEI3511 US201300825184 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 169 29B 2WC 31~ 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 5WD 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AABZA AACZT AAESR AAEVG AAHHS AAONW AAPXW AARHZ AAUAY AAVAP AAZKR ABCQN ABCUV ABDBF ABDFA ABEJV ABEML ABGNP ABJNI ABLJU ABNHQ ABOCM ABPTD ABPVW ABQNK ABVGC ABXVV ACAHQ ACCFJ ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACUFI ACUHS ACVCV ACXQS ADBBV ADEOM ADIPN ADIYS ADIZJ ADKYN ADMGS ADOZA ADQBN ADVEK ADXAS ADZMN ADZOD AEEZP AEGXH AEIMD AEMQT AENEX AEQDE AFBPY AFEBI AFFQV AFFZL AFGKR AFRAH AFTUV AFXAL AFZJQ AGMDO AGUTN AHMMS AIACR AIAGR AIURR AIWBW AJAOE AJBDE AJDVS AJEEA AJNCP ALAGY ALMA_UNASSIGNED_HOLDINGS ALXQX AMBMR AMYDB AOIJS ATGXG ATUGU AZBYB AZVAB BAFTC BAWUL BCRHZ BEYMZ BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBB EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FBQ FUBAC G-S G.N GODZA GX1 H.X H13 HF~ HZI HZ~ IH2 IHE IX1 J0M J5H K48 KBUDW KBYEO KOP KSI KSN LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NOMLY NU- O66 O9- OAUYM OBS OCZFY OHT OIG OJZSN OK1 OPAEJ OVD OWPYF P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 Q~Q R.K ROL ROX RPM RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WVDHM WXI X7M XG1 Y6R YFH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT 1OC 24P 33P AEUQT AFPWT FIJ IPNFZ WIN WRC AAFWJ AAYXX AGORE AJBYB CITATION AAMMB AEFGJ AGXDD AHGBF AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7S9 L.6 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c6221-591ece163d15b9b1dfa4b7165ad816ad5aa0c841de64eb19579fc24ef5c24ce03 |
IEDL.DBID | DR2 |
ISSN | 0009-9104 1365-2249 |
IngestDate | Thu Aug 21 14:16:15 EDT 2025 Fri May 09 12:18:28 EDT 2025 Fri Jul 11 11:53:06 EDT 2025 Fri Jul 11 09:24:55 EDT 2025 Fri Jul 11 10:10:38 EDT 2025 Thu Apr 03 07:09:35 EDT 2025 Mon Jul 21 09:11:10 EDT 2025 Tue Jul 01 03:52:25 EDT 2025 Thu Apr 24 23:05:43 EDT 2025 Wed Jan 22 16:23:24 EST 2025 Thu Apr 03 09:44:37 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Skin disease Psoriasis Cytokine T-Lymphocyte Interleukin 22 Biochemistry Inflammation Skin cytokines Biophysics Molecular biology T cells |
Language | English |
License | https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model CC BY 4.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6221-591ece163d15b9b1dfa4b7165ad816ad5aa0c841de64eb19579fc24ef5c24ce03 |
Notes | http://dx.doi.org/10.1111/j.1365-2249.2007.03511.x These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7454-1836 0000-0003-3812-9304 0000-0002-8463-3977 0000-0003-3990-5213 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2219373 |
PMID | 17900301 |
PQID | 20502764 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2219373 hal_primary_oai_HAL_hal_01705160v1 proquest_miscellaneous_68503256 proquest_miscellaneous_47491629 proquest_miscellaneous_20502764 pubmed_primary_17900301 pascalfrancis_primary_19869088 crossref_citationtrail_10_1111_j_1365_2249_2007_03511_x crossref_primary_10_1111_j_1365_2249_2007_03511_x wiley_primary_10_1111_j_1365_2249_2007_03511_x_CEI3511 fao_agris_US201300825184 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2007 |
PublicationDateYYYYMMDD | 2007-12-01 |
PublicationDate_xml | – month: 12 year: 2007 text: December 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Clinical and experimental immunology |
PublicationTitleAlternate | Clin Exp Immunol |
PublicationYear | 2007 |
Publisher | Oxford, UK : Blackwell Publishing Ltd Blackwell Publishing Ltd Blackwell Wiley Blackwell Science Inc |
Publisher_xml | – name: Oxford, UK : Blackwell Publishing Ltd – name: Blackwell Publishing Ltd – name: Blackwell – name: Wiley – name: Blackwell Science Inc |
References | 2004; 21 2001; 166 2007; 445 2005; 174 2005; 153 2004; 25 2006; 36 2002; 277 2004; 4 2002; 3 2006; 18 2000; 275 2003; 51 2007; 13 2003; 275 1993; 101 2001; 21 2007; 28 2001; 276 1990; 2 1994; 102 2007; 178 2001 2002; 168 2004; 295 2004; 173 2000; 97 2005; 5 2007; 8 2000; 164 1999; 135 2006; 203 2005; 16 1998; 101 2005; 77 2001; 98 2001; 116 2001; 10 Trickett (2022010406282747500_b26) 2003; 275 Xu (2022010406282747500_b19) 2001; 98 Broome (2022010406282747500_b20) 2003; 51 Asadullah (2022010406282747500_b30) 1999; 135 Dumoutier (2022010406282747500_b12) 2000; 164 Dumoutier (2022010406282747500_b7) 2000; 97 Kotenko (2022010406282747500_b18) 2001; 166 Boniface (2022010406282747500_b10) 2005; 174 Boyman (2022010406282747500_b3) 2007; 28 Schlaak (2022010406282747500_b5) 1994; 102 Yssel (2022010406282747500_b25) 2001 Boniface (2022010406282747500_b27) 2005; 16 Asadullah (2022010406282747500_b29) 1998; 101 Wilson (2022010406282747500_b38) 2007; 8 Dumoutier (2022010406282747500_b17) 2001; 166 Uyemura (2022010406282747500_b6) 1993; 101 Otkjaer (2022010406282747500_b36) 2005; 153 Kotenko (2022010406282747500_b15) 2001; 276 Harder (2022010406282747500_b33) 2005; 77 Lejeune (2022010406282747500_b16) 2002; 277 Vandesompele (2022010406282747500_b28) 2002; 3 Harrington (2022010406282747500_b39) 2006; 18 Wolk (2022010406282747500_b13) 2002; 168 Piskin (2022010406282747500_b37) 2004; 295 Lew (2022010406282747500_b1) 2004; 25 Xie (2022010406282747500_b14) 2000; 275 Schaerli (2022010406282747500_b21) 2004; 173 Nagalakshmi (2022010406282747500_b9) 2004; 4 Boniface (2022010406282747500_b4) 2007; 178 Aggarwal (2022010406282747500_b8) 2001; 21 Nickoloff (2022010406282747500_b34) 2007; 13 Bowcock (2022010406282747500_b32) 2001; 10 Bowcock (2022010406282747500_b22) 2005; 5 Wolk (2022010406282747500_b11) 2004; 21 Zheng (2022010406282747500_b24) 2007; 445 Gearing (2022010406282747500_b2) 1990; 2 Reich (2022010406282747500_b31) 2001; 116 Wolk (2022010406282747500_b35) 2006; 36 Liang (2022010406282747500_b23) 2006; 203 |
References_xml | – volume: 28 start-page: 51 year: 2007 end-page: 7 article-title: The pathogenic role of tissue‐resident immune cells in psoriasis publication-title: Trends Immunol – start-page: 7 year: 2001 end-page: 19 – volume: 275 start-page: 251 year: 2003 end-page: 5 article-title: T cell stimulation and expansion using anti‐CD3/CD28 beads publication-title: J Immunol Methods – volume: 10 start-page: 1793 year: 2001 end-page: 805 article-title: Insights into psoriasis and other inflammatory diseases from large‐scale gene expression studies publication-title: Hum Mol Genet – volume: 21 start-page: 1047 year: 2001 end-page: 53 article-title: Acinar cells of the pancreas are a target of interleukin‐22 publication-title: J Interferon Cytokine Res – volume: 3 start-page: 1 year: 2002 end-page: 12 article-title: Accurate normalization of real‐time quantitative RT–PCR data by geometric averaging of multiple internal control genes publication-title: Genome Biol – volume: 174 start-page: 3695 year: 2005 end-page: 702 article-title: IL‐22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes publication-title: J Immunol – volume: 153 start-page: 911 year: 2005 end-page: 18 article-title: The dynamics of gene expression of interleukin‐19 and interleukin‐20 and their receptors in psoriasis publication-title: Br J Dermatol – volume: 18 start-page: 349 year: 2006 end-page: 56 article-title: Expanding the effector CD4 T‐cell repertoire: the Th17 lineage publication-title: Curr Opin Immunol – volume: 166 start-page: 7090 year: 2001 end-page: 5 article-title: Cloning and characterization of IL‐22 binding protein, a natural antagonist of IL‐10‐related T cell‐derived inducible factor/IL‐22 publication-title: J Immunol – volume: 2 start-page: 68 year: 1990 end-page: 75 article-title: Cytokines in skin lesions of psoriasis publication-title: Cytokine – volume: 101 start-page: 783 year: 1998 end-page: 94 article-title: IL‐10 is a key cytokine in psoriasis. Proof of principle by IL‐10 therapy: a new therapeutic approach publication-title: J Clin Invest – volume: 166 start-page: 7096 year: 2001 end-page: 103 article-title: Identification, cloning, and characterization of a novel soluble receptor that binds IL‐22 and neutralizes its activity publication-title: J Immunol – volume: 5 start-page: 699 year: 2005 end-page: 711 article-title: Getting under the skin: the immunogenetics of psoriasis publication-title: Nat Rev Immunol – volume: 97 start-page: 10144 year: 2000 end-page: 9 article-title: Human interleukin‐10‐related T cell‐derived inducible factor: molecular cloning and functional characterization as an hepatocyte‐stimulating factor publication-title: Proc Natl Acad Sci USA – volume: 173 start-page: 2151 year: 2004 end-page: 8 article-title: Characterization of human T cells that regulate neutrophilic skin inflammation publication-title: J Immunol – volume: 4 start-page: 679 year: 2004 end-page: 91 article-title: Interleukin‐22 activates STAT3 and induces IL‐10 by colon epithelial cells publication-title: Int Immunopharmacol – volume: 445 start-page: 648 year: 2007 end-page: 51 article-title: Interleukin‐22, a TH17 cytokine, mediates IL‐23‐induced dermal inflammation and acanthosis publication-title: Nature – volume: 275 start-page: 31335 year: 2000 end-page: 9 article-title: Interleukin (IL)‐22, a novel human cytokine that signals through the interferon receptor‐related proteins CRF2‐4 and IL‐22R publication-title: J Biol Chem – volume: 164 start-page: 1814 year: 2000 end-page: 19 article-title: Cloning and characterization of IL‐10‐related T cell‐derived inducible factor (IL‐TIF), a novel cytokine structurally related to IL‐10 and inducible by IL‐9 publication-title: J Immunol – volume: 277 start-page: 33676 year: 2002 end-page: 82 article-title: Interleukin‐22 (IL‐22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL‐10 publication-title: J Biol Chem – volume: 295 start-page: 509 year: 2004 end-page: 16 article-title: T cells in psoriatic lesional skin that survive conventional therapy with NB‐UVB radiation display reduced IFN‐gamma expression publication-title: Arch Dermatol Res – volume: 135 start-page: 187 year: 1999 end-page: 92 article-title: Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial publication-title: Arch Dermatol – volume: 116 start-page: 319 year: 2001 end-page: 29 article-title: Response of psoriasis to interleukin‐10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin‐8/CXCR2 pathway and normalization of keratinocyte maturation publication-title: J Invest Dermatol – volume: 13 start-page: 242 year: 2007 end-page: 4 article-title: Cracking the cytokine code in psoriasis publication-title: Nat Med – volume: 21 start-page: 241 year: 2004 end-page: 54 article-title: IL‐22 increases the innate immunity of tissues publication-title: Immunity – volume: 276 start-page: 2725 year: 2001 end-page: 32 article-title: Identification of the functional interleukin‐22 (IL‐22) receptor complex: the IL‐10R2 chain (IL‐10Rbeta) is a common chain of both the IL‐10 and IL‐22 (IL‐10‐related T cell‐derived inducible factor, IL‐TIF) receptor complexes publication-title: J Biol Chem – volume: 101 start-page: 701 year: 1993 end-page: 5 article-title: The cytokine network in lesional and lesion‐free psoriatic skin is characterized by a T‐helper type 1 cell‐mediated response publication-title: J Invest Dermatol – volume: 25 start-page: 295 year: 2004 end-page: 305 article-title: Psoriasis vulgaris: cutaneous lymphoid tissue supports T‐cell activation and ‘Type 1’ inflammatory gene expression publication-title: Trends Immunol – volume: 168 start-page: 5397 year: 2002 end-page: 402 article-title: Cutting edge: immune cells as sources and targets of the IL‐10 family members? publication-title: J Immunol – volume: 102 start-page: 145 year: 1994 end-page: 9 article-title: T cells involved in psoriasis vulgaris belong to the Th1 subset publication-title: J Invest Dermatol – volume: 51 start-page: 675 year: 2003 end-page: 85 article-title: S100 protein subcellular localization during epidermal differentiation and psoriasis publication-title: J Histochem Cytochem – volume: 203 start-page: 2271 year: 2006 end-page: 9 article-title: Interleukin (IL)‐22 and IL‐17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides publication-title: J Exp Med – volume: 178 start-page: 4615 year: 2007 end-page: 22 article-title: Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation publication-title: J Immunol – volume: 98 start-page: 9511 year: 2001 end-page: 16 article-title: A soluble class II cytokine receptor, IL‐22RA2, is a naturally occurring IL‐22 antagonist publication-title: Proc Natl Acad Sci USA – volume: 16 start-page: 309 year: 2005 end-page: 19 article-title: Keratinocytes as targets for interleukin‐10‐related cytokines: a putative role in the pathogenesis of psoriasis publication-title: Eur Cytokine Netw – volume: 77 start-page: 476 year: 2005 end-page: 86 article-title: Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins publication-title: J Leukoc Biol – volume: 8 start-page: 950 year: 2007 end-page: 7 article-title: Development, cytokine profile and function of human interleukin 17‐producing helper T cells publication-title: Nat Immunol – volume: 36 start-page: 1309 year: 2006 end-page: 23 article-title: IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis publication-title: Eur J Immunol – volume: 77 start-page: 476 year: 2005 ident: 2022010406282747500_b33 article-title: Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins publication-title: J Leukoc Biol doi: 10.1189/jlb.0704409 – volume: 36 start-page: 1309 year: 2006 ident: 2022010406282747500_b35 article-title: IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis publication-title: Eur J Immunol doi: 10.1002/eji.200535503 – volume: 168 start-page: 5397 year: 2002 ident: 2022010406282747500_b13 article-title: Cutting edge: immune cells as sources and targets of the IL-10 family members? publication-title: J Immunol doi: 10.4049/jimmunol.168.11.5397 – volume: 10 start-page: 1793 year: 2001 ident: 2022010406282747500_b32 article-title: Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies publication-title: Hum Mol Genet doi: 10.1093/hmg/10.17.1793 – volume: 166 start-page: 7096 year: 2001 ident: 2022010406282747500_b18 article-title: Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity publication-title: J Immunol doi: 10.4049/jimmunol.166.12.7096 – volume: 276 start-page: 2725 year: 2001 ident: 2022010406282747500_b15 article-title: Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes publication-title: J Biol Chem doi: 10.1074/jbc.M007837200 – volume: 4 start-page: 679 year: 2004 ident: 2022010406282747500_b9 article-title: Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2004.01.008 – volume: 98 start-page: 9511 year: 2001 ident: 2022010406282747500_b19 article-title: A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.171303198 – volume: 5 start-page: 699 year: 2005 ident: 2022010406282747500_b22 article-title: Getting under the skin: the immunogenetics of psoriasis publication-title: Nat Rev Immunol doi: 10.1038/nri1689 – volume: 178 start-page: 4615 year: 2007 ident: 2022010406282747500_b4 article-title: Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation publication-title: J Immunol doi: 10.4049/jimmunol.178.7.4615 – volume: 3 start-page: 1 year: 2002 ident: 2022010406282747500_b28 article-title: Accurate normalization of real-time quantitative RT–PCR data by geometric averaging of multiple internal control genes publication-title: Genome Biol doi: 10.1186/gb-2002-3-7-research0034 – volume: 101 start-page: 783 year: 1998 ident: 2022010406282747500_b29 article-title: IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach publication-title: J Clin Invest doi: 10.1172/JCI1476 – volume: 277 start-page: 33676 year: 2002 ident: 2022010406282747500_b16 article-title: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10 publication-title: J Biol Chem doi: 10.1074/jbc.M204204200 – volume: 275 start-page: 31335 year: 2000 ident: 2022010406282747500_b14 article-title: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R publication-title: J Biol Chem doi: 10.1074/jbc.M005304200 – volume: 21 start-page: 1047 year: 2001 ident: 2022010406282747500_b8 article-title: Acinar cells of the pancreas are a target of interleukin-22 publication-title: J Interferon Cytokine Res doi: 10.1089/107999001317205178 – volume: 28 start-page: 51 year: 2007 ident: 2022010406282747500_b3 article-title: The pathogenic role of tissue-resident immune cells in psoriasis publication-title: Trends Immunol doi: 10.1016/j.it.2006.12.005 – volume: 97 start-page: 10144 year: 2000 ident: 2022010406282747500_b7 article-title: Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.170291697 – volume: 116 start-page: 319 year: 2001 ident: 2022010406282747500_b31 article-title: Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2001.01248.x – volume: 51 start-page: 675 year: 2003 ident: 2022010406282747500_b20 article-title: S100 protein subcellular localization during epidermal differentiation and psoriasis publication-title: J Histochem Cytochem doi: 10.1177/002215540305100513 – volume: 164 start-page: 1814 year: 2000 ident: 2022010406282747500_b12 article-title: Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9 publication-title: J Immunol doi: 10.4049/jimmunol.164.4.1814 – volume: 16 start-page: 309 year: 2005 ident: 2022010406282747500_b27 article-title: Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis publication-title: Eur Cytokine Netw – start-page: 7 volume-title: Current protocols in immunology year: 2001 ident: 2022010406282747500_b25 – volume: 25 start-page: 295 year: 2004 ident: 2022010406282747500_b1 article-title: Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression publication-title: Trends Immunol doi: 10.1016/j.it.2004.03.006 – volume: 102 start-page: 145 year: 1994 ident: 2022010406282747500_b5 article-title: T cells involved in psoriasis vulgaris belong to the Th1 subset publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12371752 – volume: 21 start-page: 241 year: 2004 ident: 2022010406282747500_b11 article-title: IL-22 increases the innate immunity of tissues publication-title: Immunity doi: 10.1016/j.immuni.2004.07.007 – volume: 2 start-page: 68 year: 1990 ident: 2022010406282747500_b2 article-title: Cytokines in skin lesions of psoriasis publication-title: Cytokine doi: 10.1016/1043-4666(90)90045-U – volume: 445 start-page: 648 year: 2007 ident: 2022010406282747500_b24 article-title: Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis publication-title: Nature doi: 10.1038/nature05505 – volume: 174 start-page: 3695 year: 2005 ident: 2022010406282747500_b10 article-title: IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes publication-title: J Immunol doi: 10.4049/jimmunol.174.6.3695 – volume: 101 start-page: 701 year: 1993 ident: 2022010406282747500_b6 article-title: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12371679 – volume: 203 start-page: 2271 year: 2006 ident: 2022010406282747500_b23 article-title: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides publication-title: J Exp Med doi: 10.1084/jem.20061308 – volume: 295 start-page: 509 year: 2004 ident: 2022010406282747500_b37 article-title: T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression publication-title: Arch Dermatol Res doi: 10.1007/s00403-004-0460-9 – volume: 8 start-page: 950 year: 2007 ident: 2022010406282747500_b38 article-title: Development, cytokine profile and function of human interleukin 17-producing helper T cells publication-title: Nat Immunol doi: 10.1038/ni1497 – volume: 275 start-page: 251 year: 2003 ident: 2022010406282747500_b26 article-title: T cell stimulation and expansion using anti-CD3/CD28 beads publication-title: J Immunol Methods doi: 10.1016/S0022-1759(03)00010-3 – volume: 153 start-page: 911 year: 2005 ident: 2022010406282747500_b36 article-title: The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2005.06800.x – volume: 135 start-page: 187 year: 1999 ident: 2022010406282747500_b30 article-title: Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial publication-title: Arch Dermatol doi: 10.1001/archderm.135.2.187 – volume: 18 start-page: 349 year: 2006 ident: 2022010406282747500_b39 article-title: Expanding the effector CD4 T-cell repertoire: the Th17 lineage publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2006.03.017 – volume: 166 start-page: 7090 year: 2001 ident: 2022010406282747500_b17 article-title: Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22 publication-title: J Immunol doi: 10.4049/jimmunol.166.12.7090 – volume: 173 start-page: 2151 year: 2004 ident: 2022010406282747500_b21 article-title: Characterization of human T cells that regulate neutrophilic skin inflammation publication-title: J Immunol doi: 10.4049/jimmunol.173.3.2151 – volume: 13 start-page: 242 year: 2007 ident: 2022010406282747500_b34 article-title: Cracking the cytokine code in psoriasis publication-title: Nat Med doi: 10.1038/nm0307-242 |
SSID | ssj0006662 |
Score | 2.3656368 |
Snippet | Interleukin (IL)-22 is a T cell-derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of psoriasis,... Summary Interleukin (IL)‐22 is a T cell‐derived cytokine that has been reported recently to induce cutaneous inflammation in an experimental murine model of... |
SourceID | pubmedcentral hal proquest pubmed pascalfrancis crossref wiley fao |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 407 |
SubjectTerms | Adaptive immunology Adult Aged Aged, 80 and over Analytical, structural and metabolic biochemistry Biochemistry Biochemistry, Molecular Biology Biological and medical sciences biosynthesis Cells, Cultured cytokines Dermatology Female Fundamental and applied biological sciences. Psychology Gene Expression Profiling Gene Expression Profiling - methods genetics Human health and pathology Humans Immunology inflammation Inflammation Mediators Inflammation Mediators - metabolism Innate immunity Interleukin-22 Interleukins Interleukins - biosynthesis Interleukins - genetics Interleukins - immunology Keratinocytes Keratinocytes - immunology Life Sciences Male metabolism methods Middle Aged Molecular and cellular biology Molecular biophysics psoriasis Psoriasis - immunology Receptors, Interleukin Receptors, Interleukin - metabolism Reverse Transcriptase Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction - methods RNA, Messenger RNA, Messenger - genetics Skin Skin - immunology skin disease T cells T-lymphocytes T-Lymphocytes - immunology Translational Studies Up-Regulation |
Title | role for T cell-derived interleukin 22 in psoriatic skin inflammation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2249.2007.03511.x https://www.ncbi.nlm.nih.gov/pubmed/17900301 https://www.proquest.com/docview/20502764 https://www.proquest.com/docview/47491629 https://www.proquest.com/docview/68503256 https://univ-poitiers.hal.science/hal-01705160 https://pubmed.ncbi.nlm.nih.gov/PMC2219373 |
Volume | 150 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BJRAS4lEeDY9iIa5ZxY6dbI6rqmWLKAfoSnuznNhpq62yq81uBZz4CfxGfgkzTna3gVaqEBcrLzvJ-LP9TWYyA_DOoLaGq4QLEUBxKBOjwlxGLoyRnWRRYdLUW3SPPiXDkfwwVuPW_4n-hWniQ6w_uNHI8PM1DXCT191B7j20UH9oIxGSTaxHfJJOED_6vIkkhSxdrJKq4Qopu049VzbUWalul2aK5Sl5S96fmRoFWDaZL66ipn97WF5mvn7pOngIk9VLNx4rk95ykfeK73_Eg_w_UnkED1qGywYNJB_DLVdtw50m5-W3bbh71Frzn8DhgJFzI0PezI4ZmRB-_fhpcUhcOMsojsX83C0nZxUTAnfZrJ7OCUgFq-kgDg1Ec_Pn5VMYHewf7w3DNrVDWCRC8FBl3BUOuaDlKs9ybksjc1TdlLF9nhirjImKvuTWJRJXE7IlloWQrlRYUoqzZ7BVTSu3A0whwUpdnNpMFjIrsWXjpJGR5WVuRZkHkK66URdt3HNKv3GuL-k_KDNNMqOsnKn2MtNfA-DrmrMm9scN6uwgUrQ5wSlaj74IMgyTFo6KdABvET7rliiu93DwUdMxH9SIJ9EFD2C3g67NjTPKHdbvB_BmBTeNMwH1jancdFnjY6hIpIm8_gqZStQGRHb9FUlfRTGy4ACeNwDe3D_NvPqM4uxAu_M-3TPV2amPV44djn0UB5B45N5Ylnpv_5C2XvxrxZdwz3-K995Hr2BrMV-618ghF_munx2wfD_mvwEK1F-a |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61RTwkxKMFah7tCsHRkb1evw4coj6U0KQHSKTelrW9plUrJ8qjtJz4Cfwf_gonfgkzayepoZUqpB64WIkfa3tnvt2ZnfE3AG8Uems4S2gbFcizRaB8OxGOtj20TmInVWFoIrrd_aDVF-8P_IMl-DH7Fqbkh5gvuBEyzHhNAKcF6TrKTYoWOhAVFSEFxRpnVYblnj7_gv7b-F17G4X9lvPdnd5Wy65KDNhpwLlr-7GrU402Seb6SZy4Wa5Egi6Er7LIDVTmK-WkkXAzHQgc1Simladc6NzHLZXawnaX4RYVFCfi_u0PC-4q9Av4rIwbzsminkZ06ZPX5sblXA1we0j5mfeHaowiy8taG5cZw3_ndF60tc1kufsQfs66ucyROW5MJ0kj_foHA-V_KodH8KAy4lmzRN1jWNLFKtwuy3qer8KdbpWwsAbtJqP8TYauAesxipL8-vY9Q9Sf6owRVcfoRE-PjwrGOf5lw_FgRFhJ2Zh2IvoRsOXHpU-gfyOv9BRWikGh14H5aEOG2guzWKQizrFlpYUSTubmScbzxIJwpjcyrajdqcLIibzg4qGMJMmICo-G0shInlngzq8clvQm17hmHVVTqs84C8n-R06xb1pocCNhwWvU13lLRF3eanYk7TO8TW7gnLoWbNTUeXHjmMqjRZEFmzP9ljjYkWxUoQfTMT6G7_AwEFefIUKBDg-Prz4jiHzHQ0PfgmclYhb3D2OzQoDdWcNS7X3qR4qjQ0PJjgJHGXkWBAYq1-5LubXTpl_P__XCTbjb6nU7stPe33sB90zkwSRbvYSVyWiqX6HJPEk2zNDE4NNNY_A3fWC9-Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61RVRIiEd51DxaC8HRkXezfh04RG2jhD6EoJF6W9beNa1aOVEepeXET-D38Fe48UuYWTtJDa1UIfXAxUps79q7M9_OzM54BuC1QmsNpYTxkIGanghV4KXCN14TtZPEz1QUWY_u7l7Y6Yl3B8HBAvyYfgtT5oeYbbgRMux6TQAf6LwOchuhhfZDlYmQfGKNsyrActucf0HzbfS2u4m0fsN5e2t_o-NVFQa8LOSceUHCTGZQJdEsSJOU6VyJFC2IQOmYhUoHSvlZLJg2ocBFjVxaecaFyQM8UqUt7HcRbokQx0UK2Yd56io0C_i0ihuKZFGPIrr0zWuicTFXfTweUnjm3YEaIcXystTGZbrw3yGdF1VtKyvb9-HndJbLEJnjxmScNrKvfySg_D_J8ADuVSq82yox9xAWTLECt8uinucrsLxbhSs8gm7LpehNFw0Dd98lH8mvb981Yv7UaJcSdQxPzOT4qHA5x7_uYNQfElIyd0QnEfsI1_LT0sfQu5EhPYGlol-YVXAD1CAj04x0IjKR5NizMkIJX7M81TxPHYimbCOzKrE71Rc5kRcMPKSRJBpR2dFIWhrJMwfYrOWgTG5yjTaryJlSfUYZJHsfOXm-aZuBxcKBV8ius54ocXmntSPpnM3axEL_lDmwVuPm-YMTKo4Wxw6sT9lb4lJHtFGF6U9G-BqBz6NQXH2HiASaOzy5-o4wDvwmqvkOPC0BM39-lNj9AZzOGpRq46lfKY4ObUJ2JDjSqOlAaJFy7bmUG1td-vXsXxuuw_L7zbbc6e5tP4c71u1gI61ewNJ4ODEvUV8ep2t2YXLh001D8DdoT7yo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+role+for+T+cell-derived+interleukin+22+in+psoriatic+skin+inflammation&rft.jtitle=Clinical+and+experimental+immunology&rft.au=Boniface%2C+Katia&rft.au=Guignouard%2C+Emmanuel&rft.au=Pedretti%2C+Nathalie&rft.au=Garcia%2C+Martine&rft.date=2007-12-01&rft.pub=Wiley&rft.issn=0009-9104&rft.eissn=1365-2249&rft.volume=150&rft.issue=3&rft.spage=407&rft.epage=415&rft_id=info:doi/10.1111%2Fj.1365-2249.2007.03511.x&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_01705160v1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9104&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9104&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9104&client=summon |